These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 10934109)
1. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Ichinose M; Sugiura H; Yamagata S; Koarai A; Shirato K Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):701-6. PubMed ID: 10934109 [TBL] [Abstract][Full Text] [Related]
2. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. Saleh D; Ernst P; Lim S; Barnes PJ; Giaid A FASEB J; 1998 Aug; 12(11):929-37. PubMed ID: 9707165 [TBL] [Abstract][Full Text] [Related]
3. Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD. Sugiura H; Ichinose M; Yamagata S; Koarai A; Shirato K; Hattori T Thorax; 2003 Apr; 58(4):299-305. PubMed ID: 12668791 [TBL] [Abstract][Full Text] [Related]
4. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. Ricciardolo FL; Caramori G; Ito K; Capelli A; Brun P; Abatangelo G; Papi A; Chung KF; Adcock I; Barnes PJ; Donner CF; Rossi A; Di Stefano A J Allergy Clin Immunol; 2005 Nov; 116(5):1028-35. PubMed ID: 16275371 [TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of protein-bound tyrosine nitration in airway secretions from patients with inflammatory airway disease. Sugiura H; Ichinose M; Tomaki M; Ogawa H; Koarai A; Kitamuro T; Komaki Y; Akita T; Nishino H; Okamoto S; Akaike T; Hattori T Free Radic Res; 2004 Jan; 38(1):49-57. PubMed ID: 15061653 [TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways. Ichinose M; Sugiura H; Yamagata S; Koarai A; Tomaki M; Ogawa H; Komaki Y; Barnes PJ; Shirato K; Hattori T Eur Respir J; 2003 Sep; 22(3):457-61. PubMed ID: 14516135 [TBL] [Abstract][Full Text] [Related]
7. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease. Kanazawa H; Shoji S; Yoshikawa T; Hirata K; Yoshikawa J Clin Exp Allergy; 1998 Oct; 28(10):1244-50. PubMed ID: 9824391 [TBL] [Abstract][Full Text] [Related]
8. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200 [TBL] [Abstract][Full Text] [Related]
11. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811 [TBL] [Abstract][Full Text] [Related]
12. Differences of inflammatory mechanisms in asthma and COPD. Ichinose M Allergol Int; 2009 Sep; 58(3):307-13. PubMed ID: 19628975 [TBL] [Abstract][Full Text] [Related]
13. Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia. Al-Ali MK; Howarth PH Saudi Med J; 2001 Mar; 22(3):249-53. PubMed ID: 11307112 [TBL] [Abstract][Full Text] [Related]
14. Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients. Brindicci C; Ito K; Torre O; Barnes PJ; Kharitonov SA Chest; 2009 Feb; 135(2):353-367. PubMed ID: 18719059 [TBL] [Abstract][Full Text] [Related]
15. Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis. Hernandez-Pando R; Schön T; Orozco EH; Serafin J; Estrada-García I Exp Toxicol Pathol; 2001 Sep; 53(4):257-65. PubMed ID: 11665849 [TBL] [Abstract][Full Text] [Related]
17. Type 2 nitric oxide synthase and protein nitration in chronic lung infection. Hopkins N; Cadogan E; Giles S; Bannigan J; McLoughlin P J Pathol; 2003 Jan; 199(1):122-9. PubMed ID: 12474235 [TBL] [Abstract][Full Text] [Related]
18. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
19. iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response. Koarai A; Ichinose M; Sugiura H; Tomaki M; Watanabe M; Yamagata S; Komaki Y; Shirato K; Hattori T Eur Respir J; 2002 Sep; 20(3):609-16. PubMed ID: 12358336 [TBL] [Abstract][Full Text] [Related]